Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability
- 1 January 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (1) , 71-81
- https://doi.org/10.1046/j.1523-1755.1999.00259.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Membrane-bound Form of Heparin-binding Epidermal Growth Factor-like Growth Factor Promotes Survival of Cultured Renal Epithelial CellsJournal of Biological Chemistry, 1997
- Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growthJournal of Cellular Physiology, 1997
- Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.Journal of Clinical Investigation, 1997
- Hormones, vitamins, and growth factors in cancer treatment and prevention: A critical appraisalCancer, 1996
- Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury.Journal of Clinical Investigation, 1995
- Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.Molecular Biology of the Cell, 1995
- The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.The Journal of cell biology, 1995
- Programmed Cell Death and the Control of Cell Survival: Lessons from the Nervous SystemScience, 1993
- Apoptosis in metanephric development.The Journal of cell biology, 1992
- A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGFScience, 1991